Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
NCT05196828
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
103
Enrollment
INDUSTRY
Sponsor class
Conditions
Restless Legs Syndrome
Interventions
DEVICE:
NTX100 Neuromodulation System
Sponsor
Noctrix Health, Inc.